US Patent Issued to HAMAD BIN KHALIFA UNIVERSITY on July 8 for "Antibody compositions targeting non-phosphorylated alpha-synuclein aggregates" (Qatari Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,623, issued on July 8, was assigned to HAMAD BIN KHALIFA UNIVERSITY (Doha, Qatar).

"Antibody compositions targeting non-phosphorylated alpha-synuclein aggregates" was invented by Omar El-Agnaf (Doha, Qatar), Nour Khaled Majbour (Doha, Qatar) and Nishant Vaikath (Doha, Qatar).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification provides a monoclonal antibody that specifically binds aggregated, non-phosphorylated Alpha-synuclein and a hybridoma producing it. Also disclosed are methods of generating antibodies that specifically binds aggregated, non-phosphorylated Alpha-synuclein and uses thereof. Uses of anti-Alpha-synuclein antibody...